ENT Treatment Companies

Sonova Holding AG

January 26, 2024: Announced the launch of the Phonak Audéo Paradise™ hearing aids with integrated biometrics sensing features for improved health monitoring and personalized hearing experiences.November 15, 2023: Received FDA approval for the EAS® Cochlear Implant System with features like AI-powered sound processing and integrated smart charger for improved hearing outcomes.

Medtronic plc

January 19, 2024: Launched the Stealth™ ENT Sinus System with enhanced navigation and visualization tools for improved accuracy and efficiency in sinus surgery.October 06, 2023: Acquired Intersect ENT, a developer of minimally invasive balloon sinuplasty devices, expanding its portfolio for treating chronic sinusitis.

Stryker Corporation

January 12, 2024: Unveiled the Sonoprobe® Elite ultrasonic aspirator with improved suction and tissue fragmentation capabilities for more efficient ENT procedures.September 21, 2023: Announced a collaboration with Google to develop AI-powered solutions for improving diagnosis and treatment of vocal cord disorders.

Johnson & Johnson (J&J)

December 22, 2023, Received FDA approval for the VERSA™ Transcutaneous Bone Anchored Hearing System, offering a new treatment option for conductive hearing loss patients.August 8, 2023, Expanded its ENT surgical device portfolio with the acquisition of Auris Surgical Robotics, a developer of robot-assisted ear surgery systems.

• Novartis AG


• Pfizer Inc.


• GlaxoSmithKline Pharmaceuticals


• Teva Pharmaceuticals Industries Ltd.


• Sonova Holding AG


• Starkey Laboratories Inc.


• Siemens Healthcare


• Sonic Innovations Inc.


• American Hearing Systems Inc.


• Reddy’s Laboratories Ltd.